骨肉瘤基因治疗的现状分析

国际肿瘤学杂志››2015,Vol. 42››Issue (1): 74-76.doi:10.3760/cma.j.issn.1673-422X.2015.01.020

张宁, 尤建宇, 国维纳, 赵宝林

130021长春，吉林大学中日联谊医院骨外科(张宁、尤建宇、赵宝林)；吉林大学第二医院重症监护室（国维纳）

收稿日期:2014-06-18修回日期:2014-08-05出版日期:2015-01-08发布日期:2015-01-07
通讯作者:赵宝林 E-mail:zhaobl@163.com

Status analysis of gene therapy in osteosarcoma

Zhang Ning, You Jianyu, Guo Weina, Zhao Baolin

Department of Orthopedics,China-Japan Union Hospital,JilinUniversity,Changchun 130021,China

Received:2014-06-18Revised:2014-08-05Online:2015-01-08Published:2015-01-07
Contact:Zhao Baolin E-mail:zhaobl@163.com

摘要/Abstract

摘要：目前，医学界普遍承认治疗骨肉瘤的最佳方法是基因治疗，常用的有抑癌基因治疗、反义基因治疗、自杀基因治疗、免疫基因治疗、联合基因治疗等。但是无论哪种基因治疗方法，都必须具备安全的基因载体。骨肉瘤的基因治疗方法近几年有所突破，在广泛应用的基础上，还应进一步强调基因载体的重要性。

张宁, 尤建宇, 国维纳, 赵宝林. 骨肉瘤基因治疗的现状分析[J]. 国际肿瘤学杂志, 2015, 42(1): 74-76.

Zhang Ning, You Jianyu, Guo Weina, Zhao Baolin. Status analysis of gene therapy in osteosarcoma[J]. Journal of International Oncology, 2015, 42(1): 74-76.

［1］ Rainusso N, Brawley VS, Ghazi A, et al. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumorinitiating cells in osteosarcoma［J］. Cancer Gene Ther, 2012, 19(3): 212-217. ［2］ Daft PG, Yuan K, Warram JM, et al. AlphaCaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma［J］. Mol Cancer Res, 2013, 11(4): 349-359. ［3］ Baamonde A, CurtoReyes V, Juárez L, et al. Antihyperalgesic effects induced by the IL1 receptor antagonist anakinra and increased IL1 beta levels in inflamed and osteosarcomabearing mice［J］. Life Sci, 2011, 81(8): 673-682. ［4］ Liebau C, Roesel C, Schmidt S, et al. Immunotherapy by gene transfer with plasmids encoding IL12/IL18 is superior to IL23/IL18 gene transfer in a rat osteosarcoma model［J］. Anticancer Res, 2004, 24(5A): 2861-2867. ［5］ Strander H. Interferons and osteosarcoma［J］. Cytokine Growth Factor Rev, 2007, 18(56): 373380. ［6］ Fulda S, Debatin KM. 5Aza2′deoxycytidine and IFNgamma cooperate to sensitize for TRAILinduced apoptosis by upregulating caspase8［J］. Oncogene, 2006, 25(37): 5125-5133. ［7］ Gauthaman K, Fong CY, Arularasu S, et al. Human Wharton′s jelly stem cell conditioned medium and cellfree lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice［J］. J Cell Biochem, 2013, 114(2): 366-377. ［8］ Wang YC, Zheng LH, Ma BA, et al. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma［J］. Acta Histochem, 2011, 113(4): 402-408. ［9］ Tsang WP, Chau SP, Fung KP, et al. Modulation of multidrug resistanceassociated protein 1 (MRP1) by p53 mutant in Saos2 cells［J］. Cancer Chemother Pharmacol, 2003, 51(2): 161-166. ［10］ Xie XK, Yang DS, Ye ZM, et al. Construction of antisense cmyc recombinant adenovirus and its antitumor effects on osteosarcoma cell lines MG63 and U2OS［J］. Ai Zheng, 2005, 24(3): 292-297. ［11］ Martelli L, Di Mario F, Botti P, et al. Accumulation, platinumDNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wildtype status［J］. Biochem Pharmacol, 2007, 74(1): 20-27. ［12］ Ketola A, Mtt AM, Pasanen T, et al. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy［J］. Int J Mol Med, 2004, 13(5): 705-710. ［13］ Seto M, Yamazaki T, Sonoda J, et al. Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy［J］. Oncol Rep, 2002, 9(2): 337-340. ［14］ Oosterhoff D, Witlox MA, van Beusechem VW, et al. Genedirected enzyme prodrug therapy for osteosarcoma: sensitization to CPT11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase2［J］. Mol Cancer Ther, 2003, 2(8): 765-771. ［15］ Lafleur EA, Jia SF, Worth LL, et al. Interleukin (IL)12 and IL12 gene transfer upregulate Fas expression in human osteosareoma and breast cancer cells［J］. Cancer Res, 2001, 61(10): 4066-4071. ［16］ Osaki M, Takeshita F, Sugimoto Y, et al. MicroRNA143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease13 expression［J］. Mol Ther, 2011, 19(6):1123-1130. ［17］ Nagamori M, Kawaguchi S, Murakami M, et al. In vivo immunogenicity of osteosarcoma cells that express B71a, an alternatively spliced form of B71［J］. Anticancer Res, 2009, 22(4): 2009-2013. ［18］ Posthumadeboer J, van Egmond PW, Helder MN, et al. Targeting JNKinteractingprotein1 (JIP1) sensitises osteosarcoma to doxorubicin［J］. Oncotarget, 2012, 3(10): 1169-1181. ［19］ Zhang ZY, Wang LQ, Fu CF, et al. Combination of targeting geneviro therapy with recombinant Fowlpox viruses with HN and VP3 genes on mouse osteosarcoma［J］. Eur Rev Med Pharmacol Sci, 2013, 17(6): 767-776. ［20］ Okumura K, Nakase M, Nakamura S, et al. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo［J］. Once Rep, 2012, 17(4): 769-773.

[1]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟.铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[2]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛.铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[3]	马小平, 常君丽, 孙星媛, 杨燕萍.长非编码RNA调控骨肉瘤耐药机制的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 51-54.
[4]	周仁邦, 张仲传, 许志远, 朱勋兵.miR-219a-5p通过负调控HMGA2抑制骨肉瘤U2OS细胞增殖、侵袭和迁移[J]. 国际肿瘤学杂志, 2022, 49(4): 193-198.
[5]	李炳亮, 杨娅, 黄英丽, 司文, 李兴伟, 张元民, 卞继超, 陈语.miR-20a-5p靶向KDM6B对骨肉瘤细胞增殖、迁移和侵袭能力的影响[J]. 国际肿瘤学杂志, 2021, 48(2): 65-73.
[6]	杨晓1,李思2,彭锦3,王琳4,吴衣论4,冯颖2.质膜型唾液酸酶NEU3活性对骨肉瘤MG-63细胞增殖与凋亡的影响[J]. 国际肿瘤学杂志, 2019, 46(4): 193-198.
[7]	贺启华.微小RNA-24对骨肉瘤细胞U2OS体外增殖与迁移能力的影响及作用机制[J]. 国际肿瘤学杂志, 2017, 44(7): 490-495.
[8]	袁源, 李松霖, 王忠华, 沈会华, 李悟, 王卫东.吴茱萸碱抑制Wnt/β-catenin信号通路诱导骨肉瘤MG-63细胞凋亡[J]. 国际肿瘤学杂志, 2017, 44(2): 86-90.
[9]	王伟,李召辉,郑晓霞,崔玉英.ErbB3在骨肉瘤细胞株Saos-2中的表达及其意义[J]. 国际肿瘤学杂志, 2016, 43(8): 593-596.
[10]	吴进, 陈志达, 曾文容, 林斌, 吴欣宇, 刘庆军.HERG基因调控NF-κB通道抑制骨肉瘤恶性表型的研究[J]. 国际肿瘤学杂志, 2016, 43(7): 508-514.
[11]	沈国琪，张春林.受体酪氨酸激酶在骨肉瘤和尤文肉瘤中的作用[J]. 国际肿瘤学杂志, 2015, 42(7): 551-553.
[12]	任慧文,杨澄,苏宏伟,李宏伟.微小RNA表达比在骨肉瘤中的预测作用[J]. 国际肿瘤学杂志, 2014, 41(8): 708-711.
[13]	杨澄, 苏宏伟, 任慧文, 李宏伟.骨肿瘤的发生发展及转移[J]. 国际肿瘤学杂志, 2014, 41(7): 533-536.
[14]	牛鑫, 邓志华.慢病毒载体及其在肿瘤基因治疗中的研究应用[J]. 国际肿瘤学杂志, 2014, 41(6): 422-424.
[15]	郭雨平, 汪得喜.肺癌靶向基因的研究及价值[J]. 国际肿瘤学杂志, 2013, 40(7): 512-515.